Zydus Lifesciences Limited (ZYDUSLIFE.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 876.59B |
| Enterprise Value | 987.39B |
| P/E Ratio | 28.81 |
| PEG Ratio | -1.94 |
| Price/Sales Ratio | 3.94 |
| Price/Book Ratio | 4.3 |
| Enterprise/Revenue | 4.35 |
| Enterprise/EBITDA | 17.01 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.14 |
| Operating Margin | 0.17 |
| Return On Assets | 0.08 |
| Return On Equity | 0.15 |
| Revenue | 271.48B |
| Revenue/Share | 304.39 |
| Gross Profit | 140.3B |
| EBITDA | 85.65B |
| Net Income | 50.4B |
| Diluted EPS | 50.09 |
| Total Cash | 52.16B |
| Total Cash/Share | 52.26 |
| Total Debt | 139.66B |
| Total Debt/Equity | 0.5 |
| Current Ratio | 1.02 |
| Book Value Per Share | 303.84 |
| 52-Week Change | 27.76 |
| 52-Week High | 1,266.6 |
| 52-Week Low | 835.5 |
| Moving Average 50 Days | 1,156.21 |
| Moving Average 200 Days | 1,049.88 |
| Average Volume | 1.56M |
| Shares Outstanding | 997.5M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 0.08 |
| Payout Ratio | 0.26 |
| Last Split Factor | 5:1 |
| Last Split Date | October 06, 2015 |